Considering that the position of FGF2_30 segment is located in the promoter of FGF2 (Figure S4), the observed lower FGF2_30 methylation level in patients with sarcopenia may therefore indicate a potential role of elevated FGF2 in the pathogenesis of sarcopenia. Here, FGF2 is linked to sarcopenia.